Targeting phospholipid metabolism for glioblastoma therapy.
作者信息
Huang Tianzhi, Cheng Shi-Yuan
机构信息
The Ken & Ruth Davee Department of Neurology, Lou and Jean Malnati Brain Tumor Institute, The Robert H. Lurie Comprehensive Cancer Center, Simpson Querrey Institute for Epigenetics, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
出版信息
Neuro Oncol. 2021 Mar 25;23(3):343-344. doi: 10.1093/neuonc/noaa309.
Abstract
摘要
相似文献
1
Targeting phospholipid metabolism for glioblastoma therapy.针对磷脂代谢进行胶质母细胞瘤治疗。
Neuro Oncol. 2021 Mar 25;23(3):343-344. doi: 10.1093/neuonc/noaa309.
2
PTRF/cavin-1 remodels phospholipid metabolism to promote tumor proliferation and suppress immune responses in glioblastoma by stabilizing cPLA2.PTRF/cavin-1 通过稳定 cPLA2 重塑磷脂代谢，促进胶质母细胞瘤的肿瘤增殖并抑制免疫应答。
Neuro Oncol. 2021 Mar 25;23(3):387-399. doi: 10.1093/neuonc/noaa255.
3
Temozolomide has anti-tumor effects through the phosphorylation of cPLA on glioblastoma cells.替莫唑胺通过磷酸化神经胶质瘤细胞上的 cPLA 发挥抗肿瘤作用。
Brain Res. 2019 Nov 15;1723:146396. doi: 10.1016/j.brainres.2019.146396. Epub 2019 Aug 20.
4
Glioblastoma Therapy Using Codelivery of Cisplatin and Glutathione Peroxidase Targeting siRNA from Iron Oxide Nanoparticles.氧化铁纳米粒子共递送顺铂和谷胱甘肽过氧化物酶靶向 siRNA 治疗胶质母细胞瘤。
ACS Appl Mater Interfaces. 2020 Sep 30;12(39):43408-43421. doi: 10.1021/acsami.0c12042. Epub 2020 Sep 17.
5
Phospholipid metabolites in recurrent glioblastoma: in vivo markers detect different tumor phenotypes before and under antiangiogenic therapy.复发性脑胶质瘤中的磷脂代谢物：血管生成抑制剂治疗前后的活体标志物可检测出不同的肿瘤表型。
PLoS One. 2013;8(3):e56439. doi: 10.1371/journal.pone.0056439. Epub 2013 Mar 8.
6
Progesterone at high doses reduces the growth of U87 and A172 glioblastoma cells: Proteomic changes regarding metabolism and immunity.大剂量孕酮降低 U87 和 A172 神经胶质瘤细胞的生长：关于代谢和免疫的蛋白质组变化。
Cancer Med. 2020 Aug;9(16):5767-5780. doi: 10.1002/cam4.3223. Epub 2020 Jun 26.
7
Combination therapy targeting integrins reduces glioblastoma tumor growth through antiangiogenic and direct antitumor activity and leads to activation of the pro-proliferative prolactin pathway.针对整合素的联合治疗通过抗血管生成和直接抗肿瘤活性减少胶质母细胞瘤肿瘤生长，并导致促增殖催乳素途径的激活。
Mol Cancer. 2013 Nov 20;12(1):144. doi: 10.1186/1476-4598-12-144.
8
The glioblastoma vasculature as a target for cancer therapy.作为癌症治疗靶点的胶质母细胞瘤脉管系统
Biochem Soc Trans. 2014 Dec;42(6):1647-52. doi: 10.1042/BST20140278.
9
Alkylphospholipids deregulate cholesterol metabolism and induce cell-cycle arrest and autophagy in U-87 MG glioblastoma cells.烷基磷脂可调节胆固醇代谢，并诱导U-87 MG胶质母细胞瘤细胞的细胞周期停滞和自噬。
Biochim Biophys Acta. 2013 Aug;1831(8):1322-34. doi: 10.1016/j.bbalip.2013.05.004. Epub 2013 May 21.
10
Nuclear factor-κB in glioblastoma: insights into regulators and targeted therapy.胶质母细胞瘤中的核因子-κB：对调控因子和靶向治疗的见解
Neuro Oncol. 2016 Mar;18(3):329-39. doi: 10.1093/neuonc/nov265. Epub 2015 Nov 2.
引用本文的文献
1
Chrysomycin A Reshapes Metabolism and Increases Oxidative Stress to Hinder Glioblastoma Progression.金丝桃霉素 A 通过重塑代谢并增加氧化应激来阻碍神经胶质瘤的进展。
Mar Drugs. 2024 Aug 29;22(9):391. doi: 10.3390/md22090391.
2
Phospholipases in Gliomas: Current Knowledge and Future Perspectives from Bench to Bedside.脑胶质瘤中的磷脂酶：从基础到临床的最新认识和未来展望。
Biomolecules. 2023 May 7;13(5):798. doi: 10.3390/biom13050798.
3
Blood exosomes-based targeted delivery of cPLA2 siRNA and metformin to modulate glioblastoma energy metabolism for tailoring personalized therapy.基于血液外泌体的 cPLA2siRNA 和二甲双胍靶向递送来调节脑胶质瘤能量代谢以制定个体化治疗方案。
Neuro Oncol. 2022 Nov 2;24(11):1871-1883. doi: 10.1093/neuonc/noac071.
本文引用的文献
1
PTRF/cavin-1 remodels phospholipid metabolism to promote tumor proliferation and suppress immune responses in glioblastoma by stabilizing cPLA2.PTRF/cavin-1 通过稳定 cPLA2 重塑磷脂代谢，促进胶质母细胞瘤的肿瘤增殖并抑制免疫应答。
Neuro Oncol. 2021 Mar 25;23(3):387-399. doi: 10.1093/neuonc/noaa255.
2
Proteomic identification of a marker signature for MAPKi resistance in melanoma.蛋白质组学鉴定黑色素瘤中 MAPKi 耐药的标志物特征。
EMBO J. 2019 Aug 1;38(15):e95874. doi: 10.15252/embj.201695874. Epub 2019 Jun 26.
3
Expression of Cytosolic Phospholipase A2 Alpha in Glioblastoma Is Associated With Resistance to Chemotherapy.细胞质型磷脂酶 A2α在胶质母细胞瘤中的表达与化疗耐药相关。
Am J Med Sci. 2018 Oct;356(4):391-398. doi: 10.1016/j.amjms.2018.06.019. Epub 2018 Jun 25.
4
Recent advances in cancer metabolism: a technological perspective.癌症代谢的最新进展：技术视角。
Exp Mol Med. 2018 Apr 16;50(4):1-16. doi: 10.1038/s12276-018-0027-z.
5
The role of PTRF/Cavin1 as a biomarker in both glioma and serum exosomes.PTRF/Cavin1 作为神经胶质瘤和血清外泌体生物标志物的作用。
Theranostics. 2018 Feb 7;8(6):1540-1557. doi: 10.7150/thno.22952. eCollection 2018.
6
Targeting Phospholipid Metabolism in Cancer.靶向癌症中的磷脂代谢
Front Oncol. 2016 Dec 27;6:266. doi: 10.3389/fonc.2016.00266. eCollection 2016.
7
Mapping the Human Platelet Lipidome Reveals Cytosolic Phospholipase A2 as a Regulator of Mitochondrial Bioenergetics during Activation.绘制人类血小板脂质组图谱揭示胞质磷脂酶A2是激活过程中线粒体生物能量学的调节因子。
Cell Metab. 2016 May 10;23(5):930-44. doi: 10.1016/j.cmet.2016.04.001. Epub 2016 Apr 28.
8
Congenital generalized lipodystrophy type 4 with muscular dystrophy: clinical and pathological manifestations in early childhood.先天性全身性脂肪营养不良 4 型伴肌病：婴幼儿期的临床和病理表现。
Neuromuscul Disord. 2013 May;23(5):441-4. doi: 10.1016/j.nmd.2013.02.005. Epub 2013 Mar 13.
9
Impaired contractility and detrusor hypertrophy in cavin-1-deficient mice.肌球蛋白结合蛋白 C 缺失的小鼠收缩力受损和逼尿肌肥大。
Eur J Pharmacol. 2012 Aug 15;689(1-3):179-85. doi: 10.1016/j.ejphar.2012.05.023. Epub 2012 May 27.
10
Deletion of Cavin/PTRF causes global loss of caveolae, dyslipidemia, and glucose intolerance.Cavin/PTRF的缺失导致小窝的整体缺失、血脂异常和葡萄糖不耐受。
Cell Metab. 2008 Oct;8(4):310-7. doi: 10.1016/j.cmet.2008.07.008.
Zotero 插件